Tobira Therapeutics Inc buy Quitte
Start price
21.12.15
/
50%
€8.66
Target price
21.06.16
€9.92
Performance (%)
18.02%
End price
21.06.16
€10.22
Summary
This prediction ended on 21.06.16 with a price of €10.22. The prediction had a final performance of 18.02%. Quitte has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Tobira Therapeutics Inc | - | - | - | - |
iShares Core DAX® | 0.393% | -2.618% | 11.310% | 10.727% |
iShares Nasdaq 100 | 0.394% | -10.309% | 23.697% | 33.228% |
iShares Nikkei 225® | 1.038% | -8.365% | 7.878% | 1.931% |
iShares S&P 500 | -0.046% | -4.991% | 21.704% | 34.810% |
Comments by Quitte for this prediction
In the thread Tobira Therapeutics Inc diskutieren
aussichtsreicher Kandidat
Cenicriviroc ist ein aussichtsreicher Kandidat.
beruhigend: 68 Mio Cash und eine Marktkapitalisierung von 174 Mio
(Laufzeit überschritten)
Stopped prediction by Quitte for Tobira Therapeutics Inc
Tobira Therapeutics Inc
Start price
Target price
Perf. (%)
€10.82
23.06.16
23.06.16
€11.73
02.12.16
02.12.16
250.75%
02.12.16
02.12.16
Tobira Therapeutics Inc
Start price
Target price
Perf. (%)
€12.18
27.08.15
27.08.15
€12.50
21.09.15
21.09.15
2.93%
21.09.15
21.09.15